LRIG1 and breast carcinoma: Interestingly, ADC treatment of ER-positive breast cancer cell lines (T47D, MCF7, and ZR75-1) either significantly decreased, or had little/no effect, on LRIG1 expression (Supplemental Fig. 4a).